4,5,6 Since 2008, the Food and Drug Administration (FDA) and European Medicines Agency have required that new T2D pharmacotherapies undergo rigorous cardiovascular safety clinical trials using hard cardiovascular endpoints and more stringent statistical review
Even though GLP-1 medications suppress appetite, its important to consume adequate protein, vitamins, minerals, and overall calories to support your health
The Frontiers review suggested building toward 30 to 60 minutes of daily aerobic activity
In new research released by Jacksonville, Florida-based Acosta Group, a collective of retail, marketing and foodservice agencies, 34% of consumers say they are dining out lessbad news for restaurants
While the researchers did not find evidence that people who lost more body weight had a larger reduction in cardiovascular risk, they did find that larger decreases in waist circumference (a more sensitive marker of visceral fat) accounted for roughly a third of the reduction in cardiac risk in the semaglutide group, still leaving most of the benefit unexplained by changes in body composition
Differentiation between GLP-1 receptor agonists The clinically developed GLP-1 receptor agonists have all been shown to have glucose-lowering effects
